Confirming media reports, Baxter International announced it has agreed to sell its BioPharma Solutions (BPS) business to a private equity consortium of Warburg Pincus and...
A private equity consortium of Warburg Pincus and Advent International is said to be in advanced talks to acquire medical device maker Baxter International’s biopharma...
Plans by US healthcare company Baxter International to shed its biopharma contract business as it streamlines operations after a poor 2022 earnings performance are...
US healthcare company Baxter International is planning to spend roughly $100 million to expand a sterile fill & finish facility at Halle in the German state of North...
Under a contract just announced, Baxter BioPharma Solutions will perform fill & finish services for some 60 to 90 million doses of Moderna’s Covid-19 vaccine in the US...
12.09.2016
- The International Society for Pharmaceutical Engineering (ISPE) recognized 2016 category winners Baxter BioPharma Solutions and Janssen Vaccines for their exceptional leadership in...
12.01.2016
- In a deal worth around $32 billion, Irish drug maker Shire – headquartered in Dublin but managed from Boston, Massachusetts – has agreed a takeover of US biopharmaceutical company...
04.11.2015
- Ireland-based and London-listed drugmaker Shire has agreed what is being called a “defensive” deal to buy US biotech firm Dyax, which has a breakthrough drug said to threaten one...
